ReviewIranian journal of basic medical sciences2026
Synergistic integration of exosomes and natural compounds in 3D-printed bioscaffolds: Revolutionizing diabetic wound healing through multifunctional therapeutic platforms.
Review in Iranian journal of basic medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic wounds associated with diabetes, particularly diabetic foot ulcers, are a common complication and a significant public health challenge because they heal slowly and carry a high risk of amputation. Non-healing diabetic wounds are linked to local infection, compromised immune function, vascular damage, nerve impairment, and fragile peripheral skin. Exosomes derived from stem cells share many biological effects with their source cells but have lower immunogenicity and no tumorigenic potential, while demonstrating enhanced effectiveness in promoting wound healing. Exosomes enhance wound healing by stimulating angiogenesis and cell proliferation and by regulating inflammation. When genetically modified or combined with materials, exosomes exhibit improved therapeutic capabilities, including enriched active components, targeted delivery, and enhanced penetration across physiological barriers, thereby surpassing the limitations of conventional single treatments. Natural compounds with medicinal properties have demonstrated the capacity to facilitate tissue repair. Extensive research has examined the regenerative potential of plant-based and naturally occurring substances with inflammation-reducing, oxidative stress-mitigating, pathogen-inhibiting, and collagen-enhancing properties. 3D bioprinting, an additive manufacturing technique guided by computer-generated designs, produces biocompatible 3D structures. These tissue-engineered dermal replacements outperform conventional wound-healing techniques by offering greater procedural consistency, regulatory-compliant manufacturing standards, and precise delivery of living cellular elements, signaling proteins, and bioactive compounds. This review aims to explore the synergistic integration of exosomes and natural compounds within 3D-printed bioscaffolds for diabetic wound healing. It highlights the multifunctional therapeutic potential of these advanced platforms in enhancing tissue regeneration and repair. The article also discusses current challenges and future perspectives in translating these innovative strategies into clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.